Bionano Genomics is a biotechnology company that specializes in genome mapping and analysis. It was founded in 2003 and is headquartered in San Diego, California, USA. The company's flagship product is the Saphyr system, which utilizes optical genome mapping technology to provide high-resolution analysis of structural variations in DNA.

Structural variations refer to alterations in the DNA sequence that involve larger segments of chromosomes, such as deletions, duplications, inversions, and translocations. The sevariations can play a significant role in the development of various genetic diseases and cancers.

Bionano's Saphyr system offers researchers and clinicians a powerful tool for detecting and analyzing structural variations with greater accuracy and sensitivity compared to traditional methods such as karyotyping, fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS). This technology has applications in various fields, including clinical genetics, cancer research, and agricultural genomics.

Bionano Genomics has been actively involved in research collaborations and partnerships to further develop its technology and expand its applications. The company's goal is to advance genomic research and enable precision medicine by providing innovative tools for the comprehensive analysis of the genome.